非副腎皮質ステロイド性抗炎症性点眼薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Non Corticosteroid Anti-inflammatory Eyedrops Market Insights and Forecast to 2028

• レポートコード：QY2203B13454
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、112ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の非副腎皮質ステロイド性抗炎症性点眼薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に非副腎皮質ステロイド性抗炎症性点眼薬の世界市場のxxx％を占める「オクフェン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「大人用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の非副腎皮質ステロイド性抗炎症性点眼薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの非副腎皮質ステロイド性抗炎症性点眼薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの非副腎皮質ステロイド性抗炎症性点眼薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

非副腎皮質ステロイド性抗炎症性点眼薬のグローバル主要メーカーには、Novartis AG、Allergan, Inc.、Meda Pharmaceuticals Inc、Bausch & Lomb Inc、Cigna、Similasan Corporation、Visine、Alcon、Viva Opti-Free、Bausch & Lomb、Systane、Rite Aid、Walgreens、Staples、Clear eyesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

非副腎皮質ステロイド性抗炎症性点眼薬市場は、種類と用途によって区分されます。世界の非副腎皮質ステロイド性抗炎症性点眼薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
オクフェン、ムガベ、ジクロフェナック、その他

【用途別セグメント】
大人用、子供用

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 非副腎皮質ステロイド性抗炎症性点眼薬製品概要
- 種類別市場（オクフェン、ムガベ、ジクロフェナック、その他）
- 用途別市場（大人用、子供用）
- 調査の目的
・エグゼクティブサマリー
- 世界の非副腎皮質ステロイド性抗炎症性点眼薬販売量予測2017-2028
- 世界の非副腎皮質ステロイド性抗炎症性点眼薬売上予測2017-2028
- 非副腎皮質ステロイド性抗炎症性点眼薬の地域別販売量
- 非副腎皮質ステロイド性抗炎症性点眼薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別非副腎皮質ステロイド性抗炎症性点眼薬販売量
- 主要メーカー別非副腎皮質ステロイド性抗炎症性点眼薬売上
- 主要メーカー別非副腎皮質ステロイド性抗炎症性点眼薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（オクフェン、ムガベ、ジクロフェナック、その他）
- 非副腎皮質ステロイド性抗炎症性点眼薬の種類別販売量
- 非副腎皮質ステロイド性抗炎症性点眼薬の種類別売上
- 非副腎皮質ステロイド性抗炎症性点眼薬の種類別価格
・用途別市場規模（大人用、子供用）
- 非副腎皮質ステロイド性抗炎症性点眼薬の用途別販売量
- 非副腎皮質ステロイド性抗炎症性点眼薬の用途別売上
- 非副腎皮質ステロイド性抗炎症性点眼薬の用途別価格
・北米市場
- 北米の非副腎皮質ステロイド性抗炎症性点眼薬市場規模（種類別、用途別）
- 主要国別の非副腎皮質ステロイド性抗炎症性点眼薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの非副腎皮質ステロイド性抗炎症性点眼薬市場規模（種類別、用途別）
- 主要国別の非副腎皮質ステロイド性抗炎症性点眼薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の非副腎皮質ステロイド性抗炎症性点眼薬市場規模（種類別、用途別）
- 主要国別の非副腎皮質ステロイド性抗炎症性点眼薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の非副腎皮質ステロイド性抗炎症性点眼薬市場規模（種類別、用途別）
- 主要国別の非副腎皮質ステロイド性抗炎症性点眼薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの非副腎皮質ステロイド性抗炎症性点眼薬市場規模（種類別、用途別）
- 主要国別の非副腎皮質ステロイド性抗炎症性点眼薬市場規模（トルコ、サウジアラビア）
・企業情報
Novartis AG、Allergan, Inc.、Meda Pharmaceuticals Inc、Bausch & Lomb Inc、Cigna、Similasan Corporation、Visine、Alcon、Viva Opti-Free、Bausch & Lomb、Systane、Rite Aid、Walgreens、Staples、Clear eyes
・産業チェーン及び販売チャネル分析
- 非副腎皮質ステロイド性抗炎症性点眼薬の産業チェーン分析
- 非副腎皮質ステロイド性抗炎症性点眼薬の原材料
- 非副腎皮質ステロイド性抗炎症性点眼薬の生産プロセス
- 非副腎皮質ステロイド性抗炎症性点眼薬の販売及びマーケティング
- 非副腎皮質ステロイド性抗炎症性点眼薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 非副腎皮質ステロイド性抗炎症性点眼薬の産業動向
- 非副腎皮質ステロイド性抗炎症性点眼薬のマーケットドライバー
- 非副腎皮質ステロイド性抗炎症性点眼薬の課題
- 非副腎皮質ステロイド性抗炎症性点眼薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Non Corticosteroid Anti-inflammatory Eyedrops Market
Due to the COVID-19 pandemic, the global Non Corticosteroid Anti-inflammatory Eyedrops market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Ocufen accounting for % of the Non Corticosteroid Anti-inflammatory Eyedrops global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Adult segment is altered to an % CAGR throughout this forecast period.
China Non Corticosteroid Anti-inflammatory Eyedrops market size is valued at US$ million in 2021, while the US and Europe Non Corticosteroid Anti-inflammatory Eyedrops are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Non Corticosteroid Anti-inflammatory Eyedrops landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops include Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon and Viva Opti-Free, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Non Corticosteroid Anti-inflammatory Eyedrops Scope and Segment
Non Corticosteroid Anti-inflammatory Eyedrops market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Non Corticosteroid Anti-inflammatory Eyedrops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Ocufen
Mugabe
Diclofenac
Others
Segment by Application
Adult
Children
By Company
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Non Corticosteroid Anti-inflammatory Eyedrops Product Introduction
1.2 Market by Type
1.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ocufen
1.2.3 Mugabe
1.2.4 Diclofenac
1.2.5 Others
1.3 Market by Application
1.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Estimates and Forecasts 2017-2028
2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Estimates and Forecasts 2017-2028
2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region
2.4.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2017-2022)
2.4.2 Global Sales Non Corticosteroid Anti-inflammatory Eyedrops by Region (2023-2028)
2.5 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region
2.5.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2017-2022)
2.5.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Manufacturers
3.1.1 Global Top Non Corticosteroid Anti-inflammatory Eyedrops Manufacturers by Sales (2017-2022)
3.1.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops in 2021
3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Manufacturers
3.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Manufacturers (2017-2022)
3.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non Corticosteroid Anti-inflammatory Eyedrops Revenue in 2021
3.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type
4.1.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Historical Sales by Type (2017-2022)
4.1.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Forecasted Sales by Type (2023-2028)
4.1.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2017-2028)
4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type
4.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Historical Revenue by Type (2017-2022)
4.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2017-2028)
4.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Type
4.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Type (2017-2022)
4.3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application
5.1.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Historical Sales by Application (2017-2022)
5.1.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Forecasted Sales by Application (2023-2028)
5.1.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2017-2028)
5.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application
5.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Historical Revenue by Application (2017-2022)
5.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Forecasted Revenue by Application (2023-2028)
5.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2017-2028)
5.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Application
5.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Application (2017-2022)
5.3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Type
6.1.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2028)
6.1.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2028)
6.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Application
6.2.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2028)
6.2.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2028)
6.3 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
6.3.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2017-2028)
6.3.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Type
7.1.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2028)
7.1.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2028)
7.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Application
7.2.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2028)
7.2.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2028)
7.3 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
7.3.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2017-2028)
7.3.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Type
8.1.1 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2028)
8.1.2 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2028)
8.2 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Application
8.2.1 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2028)
8.2.2 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2028)
8.3 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Region
8.3.1 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2017-2028)
8.3.2 Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Type
9.1.1 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2028)
9.1.2 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2028)
9.2 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Application
9.2.1 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2028)
9.2.2 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2028)
9.3 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
9.3.1 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2017-2028)
9.3.2 Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Type
10.1.1 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2028)
10.2 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Application
10.2.1 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2028)
10.2.2 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2028)
10.3 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
10.3.1 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Overview
11.1.3 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis AG Recent Developments
11.2 Allergan, Inc.
11.2.1 Allergan, Inc. Corporation Information
11.2.2 Allergan, Inc. Overview
11.2.3 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan, Inc. Recent Developments
11.3 Meda Pharmaceuticals Inc
11.3.1 Meda Pharmaceuticals Inc Corporation Information
11.3.2 Meda Pharmaceuticals Inc Overview
11.3.3 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Meda Pharmaceuticals Inc Recent Developments
11.4 Bausch & Lomb Inc
11.4.1 Bausch & Lomb Inc Corporation Information
11.4.2 Bausch & Lomb Inc Overview
11.4.3 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bausch & Lomb Inc Recent Developments
11.5 Cigna
11.5.1 Cigna Corporation Information
11.5.2 Cigna Overview
11.5.3 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cigna Recent Developments
11.6 Similasan Corporation
11.6.1 Similasan Corporation Corporation Information
11.6.2 Similasan Corporation Overview
11.6.3 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Similasan Corporation Recent Developments
11.7 Visine
11.7.1 Visine Corporation Information
11.7.2 Visine Overview
11.7.3 Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Visine Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Visine Recent Developments
11.8 Alcon
11.8.1 Alcon Corporation Information
11.8.2 Alcon Overview
11.8.3 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Alcon Recent Developments
11.9 Viva Opti-Free
11.9.1 Viva Opti-Free Corporation Information
11.9.2 Viva Opti-Free Overview
11.9.3 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Viva Opti-Free Recent Developments
11.10 Bausch & Lomb
11.10.1 Bausch & Lomb Corporation Information
11.10.2 Bausch & Lomb Overview
11.10.3 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bausch & Lomb Recent Developments
11.11 Systane
11.11.1 Systane Corporation Information
11.11.2 Systane Overview
11.11.3 Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Systane Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Systane Recent Developments
11.12 Rite Aid
11.12.1 Rite Aid Corporation Information
11.12.2 Rite Aid Overview
11.12.3 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Rite Aid Recent Developments
11.13 Walgreens
11.13.1 Walgreens Corporation Information
11.13.2 Walgreens Overview
11.13.3 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Walgreens Recent Developments
11.14 Staples
11.14.1 Staples Corporation Information
11.14.2 Staples Overview
11.14.3 Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Staples Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Staples Recent Developments
11.15 Clear eyes
11.15.1 Clear eyes Corporation Information
11.15.2 Clear eyes Overview
11.15.3 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Clear eyes Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non Corticosteroid Anti-inflammatory Eyedrops Industry Chain Analysis
12.2 Non Corticosteroid Anti-inflammatory Eyedrops Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non Corticosteroid Anti-inflammatory Eyedrops Production Mode & Process
12.4 Non Corticosteroid Anti-inflammatory Eyedrops Sales and Marketing
12.4.1 Non Corticosteroid Anti-inflammatory Eyedrops Sales Channels
12.4.2 Non Corticosteroid Anti-inflammatory Eyedrops Distributors
12.5 Non Corticosteroid Anti-inflammatory Eyedrops Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non Corticosteroid Anti-inflammatory Eyedrops Industry Trends
13.2 Non Corticosteroid Anti-inflammatory Eyedrops Market Drivers
13.3 Non Corticosteroid Anti-inflammatory Eyedrops Market Challenges
13.4 Non Corticosteroid Anti-inflammatory Eyedrops Market Restraints
14 Key Findings in The Global Non Corticosteroid Anti-inflammatory Eyedrops Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Ocufen
Table 3. Major Manufacturers of Mugabe
Table 4. Major Manufacturers of Diclofenac
Table 5. Major Manufacturers of Others
Table 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2017-2022) & (K Units)
Table 9. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2017-2022)
Table 10. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2023-2028) & (K Units)
Table 11. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2023-2028)
Table 12. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2017-2022)
Table 14. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2023-2028)
Table 16. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Manufacturers (2017-2022)
Table 18. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Manufacturers (2017-2022)
Table 20. Non Corticosteroid Anti-inflammatory Eyedrops Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Non Corticosteroid Anti-inflammatory Eyedrops Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Non Corticosteroid Anti-inflammatory Eyedrops by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Corticosteroid Anti-inflammatory Eyedrops as of 2021)
Table 23. Non Corticosteroid Anti-inflammatory Eyedrops Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Non Corticosteroid Anti-inflammatory Eyedrops Product Offered
Table 25. Date of Manufacturers Enter into Non Corticosteroid Anti-inflammatory Eyedrops Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2022) & (K Units)
Table 28. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2023-2028) & (K Units)
Table 29. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Type (2017-2022)
Table 30. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Type (2023-2028)
Table 31. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Type (2017-2022)
Table 34. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Type (2023-2028)
Table 35. Non Corticosteroid Anti-inflammatory Eyedrops Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Non Corticosteroid Anti-inflammatory Eyedrops Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2022) & (K Units)
Table 38. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2023-2028) & (K Units)
Table 39. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Application (2017-2022)
Table 40. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Application (2023-2028)
Table 41. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Application (2017-2022)
Table 44. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Application (2023-2028)
Table 45. Non Corticosteroid Anti-inflammatory Eyedrops Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Non Corticosteroid Anti-inflammatory Eyedrops Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2022) & (K Units)
Table 48. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2023-2028) & (K Units)
Table 49. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2022) & (K Units)
Table 52. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2023-2028) & (K Units)
Table 53. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2017-2022) & (K Units)
Table 56. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2023-2028) & (K Units)
Table 57. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2022) & (K Units)
Table 60. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2023-2028) & (K Units)
Table 61. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2022) & (K Units)
Table 64. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2023-2028) & (K Units)
Table 65. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2017-2022) & (K Units)
Table 68. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2023-2028) & (K Units)
Table 69. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2023-2028) & (US$ Million)
Table 107. Novartis AG Corporation Information
Table 108. Novartis AG Description and Major Businesses
Table 109. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novartis AG Recent Developments
Table 112. Allergan, Inc. Corporation Information
Table 113. Allergan, Inc. Description and Major Businesses
Table 114. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Allergan, Inc. Recent Developments
Table 117. Meda Pharmaceuticals Inc Corporation Information
Table 118. Meda Pharmaceuticals Inc Description and Major Businesses
Table 119. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Meda Pharmaceuticals Inc Recent Developments
Table 122. Bausch & Lomb Inc Corporation Information
Table 123. Bausch & Lomb Inc Description and Major Businesses
Table 124. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bausch & Lomb Inc Recent Developments
Table 127. Cigna Corporation Information
Table 128. Cigna Description and Major Businesses
Table 129. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Cigna Recent Developments
Table 132. Similasan Corporation Corporation Information
Table 133. Similasan Corporation Description and Major Businesses
Table 134. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Similasan Corporation Recent Developments
Table 137. Visine Corporation Information
Table 138. Visine Description and Major Businesses
Table 139. Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Visine Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Visine Recent Developments
Table 142. Alcon Corporation Information
Table 143. Alcon Description and Major Businesses
Table 144. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Alcon Recent Developments
Table 147. Viva Opti-Free Corporation Information
Table 148. Viva Opti-Free Description and Major Businesses
Table 149. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Viva Opti-Free Recent Developments
Table 152. Bausch & Lomb Corporation Information
Table 153. Bausch & Lomb Description and Major Businesses
Table 154. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Bausch & Lomb Recent Developments
Table 157. Systane Corporation Information
Table 158. Systane Description and Major Businesses
Table 159. Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. Systane Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Systane Recent Developments
Table 162. Rite Aid Corporation Information
Table 163. Rite Aid Description and Major Businesses
Table 164. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Rite Aid Recent Developments
Table 167. Walgreens Corporation Information
Table 168. Walgreens Description and Major Businesses
Table 169. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 170. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Walgreens Recent Developments
Table 172. Staples Corporation Information
Table 173. Staples Description and Major Businesses
Table 174. Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 175. Staples Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Staples Recent Developments
Table 177. Clear eyes Corporation Information
Table 178. Clear eyes Description and Major Businesses
Table 179. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 180. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Clear eyes Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Non Corticosteroid Anti-inflammatory Eyedrops Distributors List
Table 185. Non Corticosteroid Anti-inflammatory Eyedrops Customers List
Table 186. Non Corticosteroid Anti-inflammatory Eyedrops Market Trends
Table 187. Non Corticosteroid Anti-inflammatory Eyedrops Market Drivers
Table 188. Non Corticosteroid Anti-inflammatory Eyedrops Market Challenges
Table 189. Non Corticosteroid Anti-inflammatory Eyedrops Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Non Corticosteroid Anti-inflammatory Eyedrops Product Picture
Figure 3. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Type in 2021 & 2028
Figure 3. Ocufen Product Picture
Figure 4. Mugabe Product Picture
Figure 5. Diclofenac Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Application in 2021 & 2028
Figure 8. Adult
Figure 9. Children
Figure 10. Non Corticosteroid Anti-inflammatory Eyedrops Report Years Considered
Figure 11. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales 2017-2028 (K Units)
Figure 12. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue 2017-2028 (US$ Million)
Figure 14. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2017-2022)
Figure 16. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2023-2028)
Figure 17. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales YoY (2017-2028) & (K Units)
Figure 18. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Non Corticosteroid Anti-inflammatory Eyedrops Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops in the World: Market Share by Non Corticosteroid Anti-inflammatory Eyedrops Revenue in 2021
Figure 29. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2017-2028)
Figure 31. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2017-2028)
Figure 32. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2017-2028)
Figure 33. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2017-2028)
Figure 34. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2017-2028)
Figure 35. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2017-2028)
Figure 36. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2017-2028)
Figure 37. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2017-2028)
Figure 38. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country (2017-2028)
Figure 39. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Country (2017-2028)
Figure 40. U.S. Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2017-2028)
Figure 43. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2017-2028)
Figure 44. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2017-2028)
Figure 45. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2017-2028)
Figure 46. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country (2017-2028)
Figure 47. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Country (2017-2028)
Figure 48. Germany Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 49. France Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Region (2017-2028)
Figure 59. China Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 62. India Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2017-2028)
Figure 70. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2017-2028)
Figure 72. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country (2017-2028)
Figure 74. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Country (2017-2028)
Figure 75. Mexico Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Country (2017-2028)
Figure 84. Turkey Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2017-2028) & (US$ Million)
Figure 87. Non Corticosteroid Anti-inflammatory Eyedrops Value Chain
Figure 88. Non Corticosteroid Anti-inflammatory Eyedrops Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

以下、関連資料のご紹介

浸透性オイルのグローバル市場インサイト・予測（～2028年）

Global Penetrating Oil Market Insights and Forecast to 2028
QY2203B11169 2022年3月 89Pages
新型コロナウイルス感染症のパンデミックにより、世界の浸透性オイルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に浸透性オイルの世界市場の...

オメガ3多価不飽和脂肪酸（PUFA）のグローバル市場インサイト・予測（～2028年）

Global Omega 3 PUFA Market Insights and Forecast to 2028
QY2203B02134 2022年3月 115Pages
新型コロナウイルス感染症のパンデミックにより、世界のオメガ3多価不飽和脂肪酸（PUFA）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

アクリル酸2-プロピルヘプチル(2-PHA)のグローバル市場インサイト・予測（～2028年）

Global 2-Propylheptyl Acrylate (2-PHA) Market Insights, Forecast to 2028
QY2203B01339 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のアクリル酸2-プロピルヘプチル(2-PHA)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、20...

1,3-プロパンジオール (PDO)のグローバル市場インサイト・予測（～2028年）

Global 1,3-Propanediol(PDO) Market Insights and Forecast to 2028
QY2203B00031 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界の1,3-プロパンジオール (PDO)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

ロボット薬局調剤システムのグローバル市場インサイト・予測（～2028年）

Global Robotic Pharmacy Dispensing System Market Insights, Forecast to 2028
QY2203B07261 2022年3月 93Pages
新型コロナウイルス感染症のパンデミックにより、世界のロボット薬局調剤システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にロボット薬局...

パルスチェイス解析のグローバル市場インサイト・予測（～2028年）

Global Pulse-chase Analysis Market Insights, Forecast to 2028
QY2203B04973 2022年3月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のパルスチェイス解析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパルスチェイス解析...

Eインクスクリーンのグローバル市場インサイト・予測（～2028年）

Global E-ink Screens Market Insights and Forecast to 2028
QY2203B00584 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のEインクスクリーンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にEインクスクリーン...

パンクレリパーゼのグローバル市場インサイト・予測（～2028年）

Global Pancrelipase Market Insights and Forecast to 2028
QY2203B05040 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のパンクレリパーゼの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパンクレリパーゼの世...

スピンオンドーパントのグローバル市場インサイト・予測（～2028年）

Global Spin-on Dopant Market Insights, Forecast to 2028
QY2203B03540 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のスピンオンドーパントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスピンオンドーパ...

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

Global Overactive Bladder Treatment Market Insights and Forecast to 2028
QY2203B08096 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（...

浸透性オイルのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Penetrating Oil Market Due to the COVID-19 pandemic, the global Penetrating Oil market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the e…
オンライン子供服・マタニティ服のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Online Children's and Maternity Apparel Market Due to the COVID-19 pandemic, the global Online Children's and Maternity Apparel market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % d…
オメガ3多価不飽和脂肪酸（PUFA）のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Omega 3 PUFA Market Due to the COVID-19 pandemic, the global Omega 3 PUFA market size is estimated to be worth US$ 15430 million in 2022 and is forecast to a readjusted size of US$ 21390 million by 2028 with a CAGR of 5.6% during the review period. Fully consider…
パンクレリパーゼのグローバル市場インサイト・予測（～2028年） Pancrelipase (CAS 53608-75-6) is a combination of three enzymes (proteins): lipase, protease, and amylase. These enzymes are normally produced by the pancreas and are important in the digestion of fats, proteins, and sugars. Pancrelipase is used to replace these enzymes when the body does not have e…
家庭用トランポリン（子供用）のグローバル市場インサイト・予測（～2028年） Trampolines provide endless fun for kids and families and are bound to be the highlight of every sleepover, birthday party, and family reunion. Market Analysis and Insights: Global Home Children Trampoline Market Due to the COVID-19 pandemic, the global Home Children Trampoline market size is estima…